Analysed FOGHORN THERAPEUTICS INC (FHTX:NASDAQ) News Sources
Foghorn Therapeutics Presents New Preclinical Data for Selective SMARCA2 Inhibitor FHD-909 and for Selective CBP, EP300 and ARID1B Degrader Programs at the 2026 AACR Annual Meeting
21-04-2026
yahoo.com
Foghorn Therapeutics to Present New Preclinical Data for Selective SMARCA2 Inhibitor FHD-909 and Selective CBP, EP300 and ARID1B Degrader Programs at the 2026 AACR Annual Meeting
09-04-2026
yahoo.com
Strength Seen in Dianthus Therapeutics, Inc. (DNTH): Can Its 5.6% Jump Turn into More Strength?
01-04-2026
yahoo.com
Foghorn Therapeutics Provides Financial Update for 2025 and 2026 Strategic Outlook
11-03-2026
yahoo.com
Foghorn Therapeutics Strengthens Financial Leadership with Appointment of Ryan Maynard as Chief Financial Officer
23-02-2026
yahoo.com
Foghorn Therapeutics CEO Talks Lilly-Partnered SMARCA2 Phase 1 and New Degrader Targets at Conference
14-02-2026
marketbeat.com
What is the current price of FOGHORN THERAPEUTICS INC (FHTX:NASDAQ)?
The current price of FOGHORN THERAPEUTICS INC (FHTX:NASDAQ) is $5.27.
FOGHORN THERAPEUTICS INC (FHTX:NASDAQ) absolute price change since previous trading day?
The absolute price change of FOGHORN THERAPEUTICS INC (FHTX:NASDAQ) since the previous trading day is $-0.24.
FOGHORN THERAPEUTICS INC (FHTX:NASDAQ) percentage price change since previous trading day?
The percentage price change of FOGHORN THERAPEUTICS INC (FHTX:NASDAQ) since the previous trading day is -4.3557%.
What is the most recent average sentiment score for FOGHORN THERAPEUTICS INC (FHTX:NASDAQ)?
The most recent average sentiment score for FOGHORN THERAPEUTICS INC (FHTX:NASDAQ) is 72 out of 100.
What is the most recent average sentiment for FOGHORN THERAPEUTICS INC (FHTX:NASDAQ)?
The most recent sentiment for FOGHORN THERAPEUTICS INC (FHTX:NASDAQ) is .
SEC-8K** Filing Available For FOGHORN THERAPEUTICS INC (FHTX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.